National Institute on Drug Abuse; Notice of Closed Meetings, 12365-12366 [2017-04026]
Download as PDF
Federal Register / Vol. 82, No. 40 / Thursday, March 2, 2017 / Notices
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Gniesha Yvonne
Dinwiddie, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3137, Bethesda, MD 20892,
dinwiddiegy@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Understanding and Addressing the MultiLevel Influences on Uptake and Adherence to
HIV Prevention Strategies among Adolescent
Girls and Young Women in Sub-Saharan
Africa.
Date: March 24, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; International and Cooperative
Projects—1 Study Section.
Date: March 24, 2017.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 24, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04024 Filed 3–1–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sradovich on DSK3GMQ082PROD with NOTICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Sep<11>2014
16:13 Mar 01, 2017
Jkt 241001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Neurological Institute
of Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders K.
Date: March 16–17, 2017.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorder and Stroke Special
Emphasis Panel; Udall Center Review.
Date: March 20–21, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand Chicago
Riverfront, 71 East Wacker Drive, Chicago, IL
60601.
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529,
neuhuber@nihnds.nih.gov.
Name of Committee: National Institute of
Neurological Disorder and Stroke Special
Emphasis Panel; R13 Review.
Date: March 22–23, 2017.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Ernest Lyons, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–0182, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
12365
Dated: February 23, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04027 Filed 3–1–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Mechanism for Time-Sensitive Drug Abuse
Research (R21).
Date: March 16, 2017.
Time: 12:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Ivan K. Navarro, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4242, MSC 9550, Bethesda,
MD 20892, 301–827–5833, ivan.navarro@
nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Identification of Genetic and Genomic
Variants by Next-Gen Sequencing in Nonhuman Animal Models (U01).
Date: March 23, 2017.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Shang-Yi Anne Tsai,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4228, MSC 9550, Bethesda,
E:\FR\FM\02MRN1.SGM
02MRN1
12366
Federal Register / Vol. 82, No. 40 / Thursday, March 2, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
MD 20892, 301–827–5842, shangyi.tsai@
nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Extracellular Vesicle Tools, Technologies,
and Products for Neuroscience Research
(R41/R42/R43/R44).
Date: March 24, 2017.
Time: 2:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, National Institutes
of Health, DHHS, 6001 Executive Blvd.,
Room 4245, Rockville, MD 20852, (301) 827–
5817, mcguireso@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; CuttingEdge Basic Research Awards (CEBRA) (R21).
Date: March 27, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, DHHS, 6001
Executive Blvd., Room 4238, MSC 9550,
Bethesda, MD 20892–9550, 301–827–5819,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Avenir
Award Program for Genetics or Epigenetics of
Substance Use Disorders (DP1).
Date: April 7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, DHHS, 6001
Executive Blvd., Room 4238, MSC 9550,
Bethesda, MD 20892–9550, 301–827–5819,
gm145a@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 24, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04026 Filed 3–1–17; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:13 Mar 01, 2017
Jkt 241001
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2010–0164]
National Boating Safety Advisory
Council
Coast Guard, Department of
Homeland Security.
ACTION: Notice of Federal Advisory
Committee meeting.
AGENCY:
The National Boating Safety
Advisory Council and its subcommittees
members will meet on March 23, 24 and
25, 2017, in Arlington, VA, to discuss
issues relating to recreational boating
safety. These meetings will be open to
the public.
DATES: The National Boating Safety
Advisory Council will meet on
Thursday, March 23, 2017, from 8:30
a.m. to 11:30 a.m. and on Saturday,
March 25, 2017 from 9:00 a.m. to 12:00
p.m. The Boats and Associated
Equipment Subcommittee will meet on
March 23, 2017, from 2:00 p.m. to 5:00
p.m. The Prevention through People
Subcommittee will meet on March 24,
2017, from 9:00 a.m. to 11:15 a.m. The
Recreational Boating Safety Strategic
Planning Subcommittee will meet on
March 24, 2017, from 1:00 p.m. to 5:00
p.m. Please note that these meetings
may conclude early if the National
Boating Safety Advisory Council has
completed all business.
ADDRESSES: All meetings will be held in
the Ballroom of the Holiday Inn
Arlington (https://www.hiarlington.com),
4610 N Fairfax Drive, Arlington, VA
22203.
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
meeting, contact the individual listed in
the FOR FURTHER INFORMATION CONTACT
section below as soon as possible.
Instructions: You are free to submit
comments at any time, including orally
at the meetings, but if you want
committee members to review your
comment before the meetings, please
submit your comments no later than
March 6, 2017. We are particularly
interested in comments on the issues in
the ‘‘Agenda’’ section below. You must
include ‘‘Department of Homeland
Security’’ and the docket number
USCG–2010–0164. Written comments
may also be submitted using the Federal
eRulemaking Portal at https://
www.regulations.gov. If you encounter
technical difficulties with comment
submission, contact the individual
listed in the FOR FURTHER INFORMATION
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
CONTACT section below. Comments
received will be posted without
alteration at https://www.regulations.gov,
including any personal information
provided. You may review a Privacy Act
notice regarding the Federal Docket
Management System in the March 24,
2005, issue of the Federal Register (70
FR 15086).
Docket Search: For access to the
docket to read documents or comments
related to this notice, go to https://
www.regulations.gov insert USCG–
2010–0164 in the ‘‘Search’’ box, press
Enter, then click the item you wish to
view.
FOR FURTHER INFORMATION CONTACT: Mr.
Jeff Ludwig, Alternate Designated
Federal Officer of the National Boating
Safety Advisory Council, telephone
(202) 372–1061, or at jeffrey.a.ludwig@
uscg.mil.
SUPPLEMENTARY INFORMATION: Notice of
this meeting is in compliance with the
Federal Advisory Committee Act, (Title
5, U.S.C., Appendix). Congress
established the National Boating Safety
Advisory Council in the Federal Boat
Safety Act of 1971 (Pub. L. 92–75). The
National Boating Safety Advisory
Council currently operates under the
authority of 46 U.S.C. 13110 and 46
U.S.C. 4302(c). The latter requires the
Secretary of Homeland Security and the
Commandant of the Coast Guard by
delegation to consult with the National
Boating Safety Advisory Council in
prescribing regulations for recreational
vessels and associated equipment and
on other major safety matters.
Meeting Agenda
The meeting agenda and all meeting
documentation can be found at: https://
homeport.uscg.mil/NBSAC.
The agenda for the National Boating
Safety Advisory Council meeting is as
follows:
Thursday, March 23, 2017
(1) Opening remarks.
(2) Receipt and discussion of the
following reports:
(a) Chief, Office of Auxiliary and
Boating Safety, Update on the Coast
Guard’s implementation of National
Boating Safety Advisory Council
Resolutions and Recreational Boating
Safety Program report.
(b) Alternate Designated Federal
Officer’s report concerning Council
administrative and logistical matters.
(3) Presentations on the following:
(a) Recreational Boating Safety
Marketing.
(b) National Nonprofit Organization
Grant Program Update.
(c) National Recreational Boating
Safety Survey Update.
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 82, Number 40 (Thursday, March 2, 2017)]
[Notices]
[Pages 12365-12366]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04026]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Mechanism for Time-Sensitive Drug Abuse Research
(R21).
Date: March 16, 2017.
Time: 12:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Ivan K. Navarro, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH, DHHS,
6001 Executive Boulevard, Room 4242, MSC 9550, Bethesda, MD 20892,
301-827-5833, ivan.navarro@nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Identification of Genetic and Genomic Variants by
Next-Gen Sequencing in Non-human Animal Models (U01).
Date: March 23, 2017.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Shang-Yi Anne Tsai, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, NIH, DHHS,
6001 Executive Boulevard, Room 4228, MSC 9550, Bethesda,
[[Page 12366]]
MD 20892, 301-827-5842, shangyi.tsai@nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Extracellular Vesicle Tools, Technologies, and
Products for Neuroscience Research (R41/R42/R43/R44).
Date: March 24, 2017.
Time: 2:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, National Institute
on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive
Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817,
mcguireso@mail.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Cutting-Edge Basic Research Awards (CEBRA) (R21).
Date: March 27, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, National Institute
on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550,
Bethesda, MD 20892-9550, 301-827-5819, gm145a@nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Avenir Award Program for Genetics or Epigenetics of
Substance Use Disorders (DP1).
Date: April 7, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy
Chase, MD 20815.
Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, National Institute
on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550,
Bethesda, MD 20892-9550, 301-827-5819, gm145a@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: February 24, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04026 Filed 3-1-17; 8:45 am]
BILLING CODE 4140-01-P